• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[有效及疗效欠佳的化疗后结核病患者体内的天然抗体、同种反应性物质及R蛋白]

[Natural antibodies, homoreactants and R-proteins in patients with tuberculosis after effective and insufficiently effective chemotherapy].

作者信息

Vakhidova G A, Kul'berg A Ia

出版信息

Probl Tuberk. 1990(7):55-7.

PMID:2235954
Abstract

The cellular receptor decay products R proteins and resultant product-immunoglobulin complexes, homoreactants showing the properties of natural antibodies and natural anti-sheep erythrocyte antibodies were analysed in their dynamics in 116 patients with infiltrative pulmonary tuberculosis. It was found that small homoreactant levels and relatively low titers of R proteins and natural sheep anti-erythrocyte antibodies were typical of patients with a limited process and favorable course due to effective treatment, the parameters being gradually normalized in their dynamics. In patients with a disseminated destructive process running an unfavorable course, all the values were much higher before the treatment and slightly changed during an ineffective therapy. It is suggested that the findings may be useful in the clinical management of pulmonary tuberculosis to predict its course and outcomes and to evaluate the efficacy of chemotherapy.

摘要

对116例浸润性肺结核患者的细胞受体衰变产物R蛋白以及由此产生的产物-免疫球蛋白复合物、具有天然抗体和天然抗绵羊红细胞抗体特性的同源反应物的动态变化进行了分析。结果发现,由于有效治疗,病程有限且预后良好的患者,其同源反应物水平较低,R蛋白和天然抗绵羊红细胞抗体滴度相对较低,这些参数在动态变化过程中逐渐恢复正常。在播散性破坏性病程且预后不良的患者中,所有数值在治疗前都高得多,且在无效治疗期间变化不大。提示这些发现可能有助于肺结核的临床管理,以预测其病程和转归,并评估化疗疗效。

相似文献

1
[Natural antibodies, homoreactants and R-proteins in patients with tuberculosis after effective and insufficiently effective chemotherapy].[有效及疗效欠佳的化疗后结核病患者体内的天然抗体、同种反应性物质及R蛋白]
Probl Tuberk. 1990(7):55-7.
2
Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.几内亚某患者群体中肺结核的血清学标志物及抗结核治疗反应
Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):199-208.
3
[Change in the content of serum immunoglobulins A, G, M in patients with pulmonary tuberculosis and alcoholism during antibacterial and anti-alcoholism therapy].
Probl Tuberk. 1991(4):57-60.
4
[Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].[浸润性和播散性肺结核患者的继发性免疫缺陷及其骨髓系纠正]
Probl Tuberk. 1998(2):20-2.
5
[Dynamics in bacterial isolation and antigenemia in patients with infiltrative pulmonary tuberculosis].[浸润性肺结核患者细菌分离及菌血症的动态变化]
Probl Tuberk. 1994(4):23-5.
6
[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].[胸腺素在浸润性破坏性肺结核患者联合化疗中的应用]
Vrach Delo. 1989 Oct(10):57-9.
7
[The treatment of patients with destructive pulmonary tuberculosis with indomethacin and tuberculostatic preparations].[用吲哚美辛和抗结核制剂治疗破坏性肺结核患者]
Vrach Delo. 1990 May(5):76-8.
8
[Antibodies to mycobacterial antigens in patients with pulmonary tuberculosis].[肺结核患者体内针对分枝杆菌抗原的抗体]
Probl Tuberk Bolezn Legk. 2004(11):37-40.
9
[Systematic approach to detection of anti-idiotypic antibodies to antimycobacterial idiotype in man and animals].
Probl Tuberk. 1997(6):61-2.
10
[Degradation products of cell receptors and natural antibodies in patients with various forms of pulmonary tuberculosis].[不同类型肺结核患者细胞受体与天然抗体的降解产物]
Probl Tuberk. 1989(8):50-3.